Alcohol consumption may have counteractive effects on heart disease risk, study finds

Sanofi wasn’t the on­ly par­ty in­ter­est­ed in Te­va’s an­ti-TL1A an­ti­body, but it emerged as the “per­fect part­ner” to se­cure a deal worth up to $1.5

FDA bi­o­log­ics cen­ter di­rec­tor Pe­ter Marks said the agency plans to en­cour­age spon­sors to use the ac­cel­er­at­ed ap­proval path­way, par­tic­u­lar­ly for rare dis­ease treat­ments, as